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Clutia lanceolata Forssk. (C. lanceolata) is a medicinal plant native to sub-Saharan Africa and 
the Arabian Peninsula. Phytochemical investigation of the aerial parts of C. lanceolata 
yielded twenty-one coumarins including methylthio and methylsulfinyl-coumarins.  Thirteen 
of these compounds are reported here for the first time, named as cluteolin A to M.  The 
remaining eight compounds are known but have not been associated previously with C. 
lanceolata.  The structures of the previously undescribed compounds were elucidated from 
their 2D NMR and MS spectra. Single crystal X-ray analyses confirmed the structures of 
eleven compounds.  As, in Saudi Arabian tradition, C. lanceolata has been reported to have 
anti-diabetic and anti-fungal properties, the coumarins were examined for their biological 
activity.  Seven compounds strongly enhanced the glucose-triggered release of insulin by 
murine pancreatic islets, with two compounds showing more than two-fold enhancement of 
insulin secretion, compared with the standard drug glimepiride. 
Key words: Clutia lanceolata Forssk; Peraceae; Coumarins; Methylthiocoumarins; Single X-
ray crystallography; Murine islets; Insulin. 
Highlights: 
• Thirteen previously undescribed 5-methylcoumarins isolated and characterised from 
Clutia lanceolata 
• These include methylthio- and methylsulfinyl-coumarins 




The genus Clutia belongs to the plant family Peraceae (formerly categorised as 
Euphorbiaceae), which are native to Eastern and sub-Saharan Africa and the Arabian 
Peninsula (Gilbert, 1992; Aynekulu et al., 2012; Parveen et al., 2016).  In particular, in Saudi 
Arabia and nearby countries, several Clutia species have been used to treat diabetes and 
fungal infections (Aburashed et al., 2003; Mossa et al., 1990; Lulekal et al., 2014). 
Diterpenoids have been reported to be isolated from C. richardiana, (Mossa et al., 1988; 
Muhammad et al., 1994a,b; Muhammad et al., 1999; Mossa et al., 1996), including the novel 
labdane-like diterpenoid, Saudin (Mossa et al., 1985; Mossa, 1988).  This compound showed 
a significant hypoglycaemic effect on non-alloxanised fasted mice (Mossa, 1988).  Another 
species, C. abyssinica, has yielded diterpenoids (Waigh et al., 1990; Zerihun et al., 1987), 
flavonoids (Zerihun et al., 1987) and coumarins (Waigh et al., 1991). However, the 
components of Clutia lanceolata have been studied relatively rarely, with only four 
compounds (3,4-dihydroxy-2-methylbenzoic acid, 1,1’-binaphthyl-2,2’-diol, 1,3,8-trihydroxy-
6-methylanthracene-9,10-dione and 5-hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl) hepta-
1,4,6-trien- 3-one) being reported (Parveen et al., 2016). 
The wide range of pharmacological and biological activities of coumarins of natural 
and synthetic origins has been reviewed (Menezes & Diederich, 2019; Zhu & Jiang, 2018; 
Hoult & Payá, 1996). Perhaps the most well-known and widely exploited of these 
therapeutic activities is the anticoagulant activity of warfarin and its analogues (Najmanová 
et al., 2015). Naturally occurring coumarins have also found applications outside medicine, 
including perfumery, dyes, laser technology and fluorescent indicators (Dittmer et al., 2005). 
The pharmacological activities of simple coumarins include anti-bacterial, anti-fungal, anti-
retroviral, anti-inflammatory, anti-depressant and anti-cancer effects (Kumar et al., 2015).  
Coumarins have also been reported to decrease the glucose concentrations in blood (Marles 
& Farnsworth, 1995).  Coumarins and terpenoids present in plant extracts from Anacardium 
occidentale caused a decrease in the blood glucose in diabetic rats (Ojewole, 2003).  Further 
studies also suggested that a coumarin and its derivative, umbelliferone, reduced the blood 
glucose levels in diabetic rats (Marles & Farnsworth, 1995; Ojewole 2003; Ramesh & 
Pugalendi, 2006). 
In the present work, a phytochemical analysis has been conducted on the coumarin 
components of Clutia lanceolata Forssk (Peraceae) as part of our continuing research into 
the isolation and characterisation of previously undescribed specialised metabolites from 
medicinal plants found in Saudi Arabia.  This plant is locally named as Laukh, A’lwah, or Saeer 
and is found in the regions Asir and Western Heights of Saudi Arabia (Rahman et al., 2004). 
The plant has been previously reported for hypoglycaemic activity (Mossa et al., 2000) and 
antifungal activity (Baka, 2010).  We report herein the isolation and structure determination 
of twenty-one coumarins (Fig. 1), after extensive chromatography of extracts. Compounds 1-
13 are previously undescribed and are named as cluteolin A to M.  Eight known coumarins 
14-21 are, for the first time, confirmed as natural compounds from C. lanceolata, although 
they have been reported as synthetic products or in isolates from other plants. Structural 
characterisation was achieved through a range of spectroscopic techniques and the 
structures of 1,8,9,11,12,14-17, 19,20 (Fig. 2) have also been characterised by single-crystal 
X-ray analysis. Furthermore, 1-4,8-9,12,14-17, 19,20 were examined for their ability to 
stimulate the glucose-triggered release of insulin from pancreatic islets. 
2. Results and Discussion 
2.1. Structure determination 
Compounds 1-21 were isolated and purified from the aerial parts of C. lanceolata. 
The structure of each compound was determined using a combination of HRESIMS, 1H and 
13C NMR (including DEPT), 2D NMR techniques (COSY, HSQC, HMBC), IR spectroscopy and, 
where possible, (1,8,9,11,12,14-17,19,20), single-crystal X-ray analysis.  Details of the various 
characterisation techniques for 1-13 are located in the electronic supplementary data (ESI), 
Figures S1 to S73.  The spectroscopic data for 14-21 were consistent with those in the 
literature. 
2.1.1. Compound 1 
Compound 1 was obtained as a colourless crystalline solid. Positive-ion HRESIMS 
showed a strong protonated molecular ion at m/z 221.0631 (calc. 221.0636), corresponding 
to the molecular formula C12H12O2S. The 13C NMR and DEPT spectra confirm the presence of 
twelve carbon signals, of which there are 3 × CH3, 3 × CH and 6 × Cq (including one carbonyl).  
The 1H and 13C NMR assignments (Table 1) are based on the COSY, HSQC and HMBC spectra. 
The IR spectrum showed a strong peak at 1704 cm-1, consistent with a lactone carbonyl 
stretch. The spectra suggested a coumarin core for the structure (Waigh et al., 1991, 
Günther et al., 1975). The 1H NMR signals at δ 7.09 (d, J = 7.5 Hz) (H-6), δ 7.31 (t, J = 7.5 Hz) 
(H-7) and δ 7.18 (d, J = 7.5 Hz) (H-8) were appropriately linked by COSY cross-peaks and 
comprised three adjacent protons on the carbocyclic ring. HSQC linked these signals to the 
13C signals at δ 128.85 (C-6), δ 129.88 (C-7) and δ 115.48 (C-8), respectively. The chemical 
shift of the signal of C-8 identified this as being ortho to oxygen, thus the coumarin is 
substituted at C-3, C-4 and C-5. The 1H signals for these substituents were consistent with 
ArCH3 / ArSCH3. One of the ArCH3 signals (δ 2.46) showed three-bond HMBC connectivity 
with the C-2 carbonyl (δ 160.53) and is thus assigned the methyl group attached at C-3; 
HSQC then identified the corresponding methyl carbon at δ 17.41. The other ArCH3 (δH 2.89 / 
δC 24.98) was shown to be located at C-5 by a two-bond HMBC cross-peak from the CH3 
protons to C-5 (δ 136.87) and three-bond cross-peaks to C-6 (δ 128.85) and to C-4a (δ 
120.18). The methylthio group (δH 2.36 / δC 20.21) was also located by HMBC, with its sole 
cross-peak to C-4 (δ 151.66). The latter had been identified by its downfield chemical shift as 
the β-carbon of an enone. Furthermore, the structure of 1 was unambiguously confirmed by 
single crystal X-ray analysis. Thus 1 is firmly identified as 3,5-dimethyl-4-methylthiocoumarin 
and is named cluteolin A. 
2.1.2. Compound 2 
Compound 2 was a white powder. The molecular formula of C13H14O3S was 
established by observation of a protonated molecular ion at m/z 251.0737 for [M + H]+ (calc. 
251.0742). Thirteen discrete signals were seen in the 13C NMR spectrum, comprising 4 × CH3, 
2 × CH and 7 × Cq. COSY, HSQC and HMBC spectra allowed assignment of all the NMR signals. 
The core heterocycle was a coumarin. The 1H chemical shifts of the methyl protons (Table 1) 
indicated that one group was a methoxy (δ 3.83) and that three were ArCH3 or ArSCH3 
(δ 2.35, δ 2.43, δ 2.86). An HMBC cross-peak from the methoxy protons to C-7 (δ 160.47) 
confirmed the location of this group. The methylthio group (δ 2.35) also only gave one HMBC 
correlation, which was to C-4 (δ 151.65). One ArCH3 (δ 2.43) was located at C-3 through a 
three-bond HMBC correlation to the carbonyl C-2 (δ 160.87). The other (δ 2.86) was located 
at C-5 and gave HMBC cross-peaks to C-4a (δ 113.91), C-5 (δ 138.42) and C-6 (δ 116.91). The 
position of this ArCH3 group was confirmed additionally by observation of HMBC cross-peak 
between H-6 (δ 6.68) and ArCH3 (δ 25.25). Compound 2 is thus shown to be 3,5-dimethyl-7-
methoxy-4-methylthiocoumarin and is named as cluteolin B.  
2.1.3. Compound 3 
Compound 3 was also obtained as white powder. The positive-ion HRESIMS showed a 
sodium adduct ion at m/z 289.0500 for [M + Na]+ (calc. 289.0511) and a protonated 
molecular ion m/z 267.0681 [M + H]+ (calc. 267.0691), corresponding to the molecular 
formula C13H14O4S. At higher mass, m/z 555.1112 corresponded to [2 M + Na]+ (calc. 
555.1123) and m/z 533.1294 corresponded to [2 M + H]+ (calc. 533.1304). The 13C NMR 
spectrum showed discrete signals for thirteen carbons, which were shown by DEPT to 
consist of 4 × CH3, 2 × CH and 7 × Cq. Most of the 1H and 13C signals were assigned readily 
from HSQC and HMBC spectra and the core was established as a coumarin, consistent with a 
lactone carbonyl stretching band at 1719 cm-1 in the IR spectrum. The 1H NMR spectrum 
(Table 1) showed only two ArH as singlets at δ 5.88 (H-3) and at δ 6.90 (H-6). The signal for 
H-3 was identified on the basis of its chemical shift and a two-bond HMBC cross-peak to the 
carbonyl C-2 (δ 157.45). The other singlet was assigned as H-6 through three-bond HMBC 
correlations with the CH3 at C-5 (δ 24.77), with C-4a (δ 111.62) and with C-8 (δ 133.80). 
Interestingly, a weak four-bond correlation was observed to C-4 (δ 159.79). The S-Me was 
shown to be attached to C-4 by an HMBC cross-peak from the 1-H signal at δ 2.50 to C-4. 
Four-bond HMBC correlation was also seen to C-3 (δ 103.70). One of the methoxy groups (δH 
3.83, δC 56.16) is located at C-7, as shown by an HMBC cross-peak to C-7 (δ 153.71). Similarly, 
the other methoxy group (δH 3.69, δC 60.62) was confirmed at C-8 (δ 133.80) by an 
appropriate HMBC cross-peak. Therefore, 3 is 7,8-dimethoxy-5-methyl-4-
methylthiocoumarin, which we name cluteolin C.     
2.1.4. Compound 4 
Compound 4 formed an amorphous white powder. The HRESIMS showed a 
protonated molecular ion at m/z 223.0421, being [M + H]+ (calc. 223.0429) for the molecular 
formula C11H10O3S. Correspondingly, eleven discrete signals were observed in the 13C NMR 
spectrum. There were 2 × CH3, 3 × CH and 6 × Cq. As for 1-3, the core heterocycle was a 
coumarin. Signals for three ArH were evident in the 1H NMR spectrum (Table 1). The singlet 
at δ 6.09 was assigned readily to H-3 on the basis of its chemical shift. HSQC then identified 
the C-3 signal at δ 106.49. The other two ArH were doublets, δ 6.97 (J = 8.3 Hz) and δ 7.00 (J 
= 8.2 Hz), which are adjacent on the carbocyclic ring. A three-bond HMBC correlation from 
the δ 6.97 signal to the ArCH3 (δ 24.16) showed that these were also adjacent on the 
carbocyclic ring. The signal at δ 6.97 also showed a weak four-bond HMBC cross-peak with C-
4 (δ 159.91), confirming that it corresponds to H-6. Thus, the signal at δ 7.00 is for H-7 and 
locates the ArCH3 at C-5. The S-Me protons (δ 2.58) gave an HMBC cross-peak with C-4 
(δ 159.91). The broad NMR signal for the phenolic OH was seen downfield at δ 9.97. 
Therefore, 4 is 8-hydroxy-5-methyl-4-methylthiocoumarin and is named cluteolin D.     
2.1.4. Compound 5 
Compound 5 was again a white powder. In the positive-ion HRESIMS, a sodium 
adduct ion was observed at m/z 289.0498 ([M + Na]+, calc. 289.0517) and a protonated 
molecular ion was seen at m/z 267.0679 ([M + H]+, calc. 267.0697), showing the molecular 
formula to be C13H14O4S. The negative-ion spectrum showed the ion [M - H]- at m/z 265.0536 
(calc. 265.0541). The formula was supported by observation of thirteen discrete resonances 
in the 13C NMR spectrum: 4 × CH3, 1 × CH and 8 × Cq. The 1 D and 2D NMR data confirmed 
that the core was a coumarin. The IR spectrum contained absorption bands for hydroxy 
(3352 cm-1) and lactone carbonyl (1703 cm-1), the former pointing towards the presence of a 
phenolic OH. The methylthio group gave NMR signals at δH 2.36 and δC 19.78 (Table 2). There 
was an HMBC correlation from these protons to C-4 (δ 151.35) only. There were two ArCH3 
groups, one of which (δH 2.29, δc 16.56) was assigned as attached to C-3 on the basis of 
HMBC correlation with C-4 and with the carbonyl carbon C-2 (δ 159.41). The other ArCH3  
(δH 2.72, δC 24.34) was located at C-5 (δ 130.83), using the two-bond HMBC cross-peak from 
the methyl signal to C-5 and the three-bond cross-peaks to C-4a (δ 112.41) and C-6 
(δ 117.17). Weak four-bond HMBC cross-peaks were also seen to C-4 and to C-7 (δ 146.58). 
An HMBC cross-peak from the sole ArH (δH 6.69) to the 13C signal at δ 130.83, identifying the 
latter as being due to C-8. C-8 is the point of attachment of the methoxy group, with an 
HMBC cross-peak from the OCH3 signal at δ 3.80. These data and inferences confirm that 5 is 
3,5-dimethyl-7-hydroxy-8-methoxy-4-methylthiocoumarin, which is named as cluteolin E.  
2.1.6. Compound 6 
Compound 6 was isolated as white crystals. Sodium adduct and protonated 
molecular ions were evident in the HRESIMS in positive-ion mode at m/z 275.0340 ([M + 
Na]+, calc. 275.0354) and at m/z 253.0522 ([M + H]+, calc. 253.0535) confirming the 
molecular formula as C12H12O4S. Ions were also seen at m/z 527.0793 ([2 M + Na]+, calc. 
527.0811) and at m/z 505.0974 ([2 M + H]+, calc. 505.0991). The IR spectrum showed a 
carbonyl absorption at 1729 cm-1.  
The core of the molecule was shown by combined use of spectroscopic techniques to 
be coumarin. The 1H NMR signal (Table 2) for H-3 was identified by two-bond HMBC 
correlation with the carbonyl carbon C-2 (δ 158.76) and C-4 (δ 166.57). C-4 showed a strong 
HMBC cross-peak with the methyl signal at δ 2.80. Thus the methylsulfinyl group is attached 
at C-4. The downfield chemical shift of the C-4 signal is consistent with being attached to an 
electron-withdrawing sulfoxide. Turning to the carbocyclic ring, an ArH signal was seen at δ 
6.99 as a doublet (J = 2.9 Hz). This is meta-coupled to the other ArH at δ 6.87 (m). The 
complex multiplicity of the latter signal is due to long-range coupling to the ArCH3, which 
shows it to be due to H-6. Thus the doublet signal is due to H-8. The ArCH3 is attached at C-5, 
with HMBC cross-peaks to C-5 (δ 137.24), to C-4a (δ 108.35) and to C-6 (δ 115.98). The 
methoxy group gave resonances at δH 3.86 and δC 56.04 and was linked to C-7 (δ 162.14), as 
shown by HMBC. Taken together, these data show that 6 is 7-methoxy-5-methyl-4-
methylsulfinylcoumarin, named as cluteolin F.      
2.1.7. Compound 7 
Compound 7 was isolated as white solid. The positive-ion HRESIMS indicated that its 
molecular formula was C13H14O5S, with a sodium adduct ion at m/z 305.0448 ([M + Na]+, 
calc. 305.0460) and a protonated molecular ion at m/z 283.0629 ([M + H]+, calc. 283.0640). 
Higher-mass ions were seen at m/z 587.1010 ([2 M + Na]+, calc. 587.1022) and m/z 565.1190 
([2 M + H]+, calc. 565.1202). Correspondingly, the 13C NMR spectrum contained thirteen 
discrete resonances, comprising 4 × CH3, 2 × CH and 7 ×Cq. Combined interpretation of the 
2D NMR spectra again showed the core to be a coumarin. Two singlets were observed in the 
1H NMR spectrum in the ArH region. The singlet at δ 7.22 (Table 2) showed HMBC cross-
peaks only to the carbonyl C-2 (δ 159.31), C-4 (δ 165.62) and C-4a (δ 108.57), confirming that 
it is due to H-3. The methylsulfinyl unit gave resonances at δH 2.77 / δC 43.59 and it was 
demonstrated to be attached to C-4 through an HMBC cross-peak. The downfield chemical 
shift of C-4 allowed its clear identification. The ArCH3 (δH 2.47. δC 15.88) had HMBC cross-
peaks to the previously identified C-4a, to C-5 (δ 127.83) and to C-6 (δ 145.15). The 
downfield chemical shift of C-6 suggested that it carried an oxygen function, which was 
confirmed as a methoxy group (δH 3.80, δC 60.86) by HMBC. The remaining ArH was 
identified as H-8 by HMBC cross-peaks to C-4a, C-6, C-7 (δ 156.59) and C-8a (δ 152.19). 
Finally, the remaining methoxy group (δH 3.95, δC 56.37) was located at C-7 by HMBC. Thus, 
7 is 6,7-dimethoxy-5-methyl-4-methylsulfinylcoumarin, named as cluteolin G. 
2.1.8. Compound 8 
Compound 8 was a colourless crystalline solid. In HRESIMS in positive-ion mode, a 
protonated molecular ion at m/z 205.0859 was evident, corresponding to [M + H]+ (calc. 
205.0847) for the molecular formula C12H12O3. The 13C NMR spectrum contained signals for 
twelve discrete carbons, of which there were 3 × CH3, 3 × CH and 6 × Cq. The core structure 
was a coumarin. The IR spectrum features a carbonyl lactone at 1696 cm-1. The 1H NMR 
spectrum contained signals for three ArH, comprising a singlet at δ 7.62 and a singlet (2 H) at 
δ 6.66 (Table 2). The former was assigned as H-4 on the basis of its chemical shift, with C-4 
resonating at δ 136.65. One ArCH3 (δH 2.20, δC 17.38) was identified as being attached at C-3 
through HMBC correlations to C-4 and the carbonyl C-2 (δ 162.82). The other ArCH3 (δH 2.45, 
δC 18.48) was located at C-5 through HMBC cross-peaks with C-6 (δ 113.86) and with C-4a (δ 
112.28). H-6 also showed an HMBC link to C-8 (δ 98.42).  H-8 (δ 6.66) correspondingly 
showed an HMBC interaction with C-6. The methoxy group (δH 3.83, δC 55.55) was attached 
at C-7 (δ 161.45). Single crystal X-ray analysis confirmed the structure of 8 unambiguously. 
Taken together, these interpretations confirm that 8 is 3,5-dimethyl-7-methoxycoumarin, 
named cluteolin H.  
2.1.9. Compound 9 
 Compound 9 comprised colourless crystals. The positive-ion HRESIMS showed the 
protonated molecular ion for [M+H]+ at m/z 221.0809 (calc. 221.0814), corresponding to the 
molecular formula C12H12O4. Correspondingly, the 13C NMR spectrum showed twelve 
discrete resonances: 3 × CH3, 2 × CH and 7 × Cq. As expected, the core heterocycle was a 
coumarin, with the IR band for the lactone carbonyl at 1698 cm-1. One ArCH3 (δH 2.20, 
δC 17.44) (Table 3) was shown to be located at C-3 by HMBC cross-peaks to the carbonyl C-2 
(δ 161.83) and to C-4 (δ 137.34). HSQC linked C-4 to H-4 (δ 7.61). On the carbocyclic ring, C-5 
was identified through HMBC correlation with H-4. C-5 showed a two-bond HMBC cross-
peak with the remaining ArCH3 (δH 2.41, δC 18.33). H-6 was characterised by two-bond HMBC 
correlations with C-5 and C-7 (δ 146.93) and three-bond HMBC correlations with C-4a (δ 
112.58) and C-8 (δ 131.76). Clearly, both C-7 and C-8 carry an oxygen function. These were 
differentiated by the phenolic OH resonating as a sharp singlet at δ 6.03, which exhibited a 
two-bond HMBC cross-peak to C-7 (δ 146.93) and three-bond HMBC cross-peaks to C-6 and 
C-8; therefore C-7 carries the hydroxy group. Finally, an HMBC correlation from the methoxy 
signal at δH 4.06 to C-8 confirmed its location at C-8. Single crystal X-ray analysis confirmed 
the structure of 9 unambiguously. Thus, 9 is 3,5-dimethyl-7-hydroxy-8-methoxycoumarion, 
named cluteolin I. 
2.1.10. Compound 10 
Compound 10 was a colourless powdery material. The molecular formula of C13H14O5 
was confirmed by a sodium adduct ion in the positive-ion HRESIMS at m/z 273.0726 ([M + 
Na]+, calc. 273.0739) and a protonated molecular ion at m/z 251.0907 ([M + H]+, calc. 
251.0920). The 13C NMR spectrum duly showed thirteen discrete signals: 4 × CH3, 1 × CH and 
8 × Cq. Together, these spectra showed a coumarin core. The IR spectrum supported this 
with a lactone carbonyl band at 1694 cm-1. Also evident was the O−H stretch of an alcohol at 
3355 cm-1.  Considering first the heterocyclic ring, the ArCH3 signal at δ 2.00 (Table 3) showed 
three-bond HMBC correlations to the carbonyl C-2 (δ 163.38) and to C-4 (δ 166.59); a two-
bond HMBC cross-peak linked this methyl group to C-3 (δ 109.87). Attached at the C-4 was a 
methoxy group (δH 3.80, δC 60.70), as demonstrated by HMBC. As for other compounds in 
this series an ArCH3 was located at C-5, as demonstrated by a two-bond HMBC correlation 
from the methyl protons (δ 2.49) to C-5 (δ 119.48). The relatively upfield chemical shift of 
this carbon and the relatively downfield shift of C-4 in 10 are a consequence of the electronic 
properties of the methoxy group at C-4. Further HMBC correlations from the methyl at C-5 
to C-4a (δ 108.84) and C-6 (δ 141.38) helped in characterising these resonances. The 
chemical shift of C-6 suggested attachment to an oxygen function but this was demonstrated 
to be hydroxy, rather than methoxy, by the absence of a HMBC cross-peak to the remaining 
methoxy group signal (δH 3.88). However, these methoxy protons were correlated by HMBC 
to the signal at (δC 150.49), which was assigned as C-7. The sole ArH (δ 6.93) showed two-
bond HMBC correlations with C-7 and C-8a (δ 147.44) and three-bond cross-peaks with C-6 
and C-4a. The chemical shift of C-8 (δ 97.64) was consistent with its location ortho to two 
oxygen functions. Compound 10 is therefore demonstrated to be 4,7-dimethoxy-3,5-
dimethyl-6-hydroxycoumarin, named as cluteolin J.        
2.1.11. Compound 11 
Compound 11 formed white crystals. In the HRESIMS in positive-ion mode, a 
protonated molecular ion at m/z 235.0962 ([M+H]+ at m/z calc. 235.0970) corresponded to 
the molecular formula C13H14O4. Ions corresponding to clusters of 11 with sodium were seen 
at m/z 491.1671 ([2 M+ Na]+ calc. 491.1682) and m/z 959.3453 ([4 M + Na]+, calc. 959.3466). 
Correspondingly, signals for thirteen carbons were seen in the 13C NMR spectrum: 4 × CH3, 2 
× CH and 7 × Cq. The core of the molecule was a coumarin, with a carbonyl stretching band 
in the IR spectrum at 1711 cm-1. An ArCH3 group was evident in the NMR spectra at δH 2.09, 
δC16.69 (Table 3). HMBC cross-peaks from these protons were observed to carbonyl C-2 (δ 
161.17), to C-3 (δ 120.66) and to C-4 (δ 137.57), locating this methyl at C-3. HSQC from C-4 
and HMBC from this ArCH3 identified H-4 (δ 7.93). From here, signals corresponding to the 
carbocyclic ring could be assigned. HMBC interactions from H-4 identified C-4a (δ 112.35), H-
8a (δ 146.96) and C-5 (δ 130.80). C-5 carries a methyl group (δH 2.45, δC 18.03), as 
demonstrated by HMBC. Further HMBC from this methyl allowed assignment of C-6 (δ 
110.50) and thus its attendant H-6 (δ 6.95). The latter chemical shifts indicate the presence 
of an ortho oxygen function. HMBC cross-peaks from H-6 confirmed C-4a and C-5 and 
identified C-7 (δ 153.58) and C-8 (δ 133.17), the latter two signals having been differentiated 
on the basis of comparison of their chemical shifts with those in the close analogue 3. One 
methoxy group (δH 3.87, δC 56.21) was shown by HMBC to be attached to C-7, whereas the 
other (δH 3.75, δC 60.73) was attached at C-8. Single crystal X-ray analysis confirmed the 
structure of 11 unambiguously. Compound 11 is thus shown to be 7,8-dimethoxy-3,5-
dimethylcoumarin, named cluteolin K.   
2.1.12. Compound 12 
Compound 12 was obtained as colourless crystals. The positive-ion HRESIMS showed 
a sodium adduct ion at m/z 243.0624 ([M + Na]+, calc. 243.0633) and a peak for [2 M + H]+ at 
m/z 463.1357 (calc. 463.1369), indicating the molecular formula C12H12O4. Thus 12 is an 
isomer of 9. However, the base peak in the mass spectrum was at m/z 203.0699 [M + H – 
H2O]+, calc. 203.0708), strongly suggesting the presence of ArCH2OH. The core structure was 
a coumarin. The 13C NMR spectrum contained twelve discrete signals: 2 × CH3, 1 × CH2, 3 × 
CH and 6 × Cq. The IR spectrum showed a band at 3435 cm-1 for the hydroxy group. The 
lactone carbonyl stretching frequency was 1668 cm-1, suggesting intramolecular H-bonding. 
The methylene protons resonate at δ 4.68 (Table 4). This signal has HMBC cross-peaks to 
carbon signals at δ 114.50 (C-3), at δ 164.39 and at δ 168.18. An HMBC cross-peak between 
the latter and the methoxy resonance at δ 4.06 distinguished these two carbon resonances 
and confirmed that the methoxy group was attached at C-4 (δ 168.18). The COSY spectrum 
indicated three adjacent protons on the carbocyclic ring. The ArCH3 (δH 2.70, δC 22.61) was 
shown to be located at C-5 (δ 137.09) through a two-bond HMBC correlation. Three-bond 
correlations were observed to the Cq at δ 116.24 (C-4a) and to C-6 (δ 128.31). A weak four-
bond HMBC cross-peak linked the ArCH3 to C-4. HSQC from C-6 identified H-6 (δ 7.08). From 
here, strong three-bond HMBC cross-peaks were seen to C-4a and to C-8 (δ 115.40), whereas 
the two-bond HMBC cross-peaks to C-5 and to C-7 (δ 131.09) were weaker. The H-7 signal 
was identified as the triplet at δ 7.40 and H-8 resonated as a doublet at δ 7.21. Together, 
these data show that 12 is 3-hydroxymethyl-5-methylcoumarin. This structure is capable of 
forming an intramolecularly H-bonded six-membered ring. Single crystal X-ray analysis 
confirmed the structure of 12 unambiguously. This compound is named cluteolin L.   
2.1.13. Compound 13 
Compound 13 was obtained as a white solid. Positive-ion HRESIMS showed that the 
molecular formula was C13H14O5, with a sodium adduct ion at m/z 273.0730 ([M + Na]+, calc. 
273.0734) and a protonated molecular ion at m/z 251.0911 (low abundance, [M + H]+, calc. 
251.0920). A cluster ion [2 M + Na]+ was observed at m/z 523.1571 (calc. 523.1580) and the 
base peak corresponded to [M + H - H2O]+ (m/z 233.0805).  The IR spectrum of 13 contained 
bands for OH (3410 cm-1) and for lactone carbonyl (1707 cm-1). This pattern was very similar 
to that for 12, indicating that they were likely to be analogues. As in 1-12, a methyl (δH 2.63, 
δC 22.78) was present at C-5, as demonstrated by HMBC cross-peaks to C-4a (δ 109.68), C-5 
(δ 138.53) and C-6 (δ 116.48). HSQC then identified H-6 (δ 6.66) through a cross-peak to C-6. 
A two-bond HMBC cross-peak from H-6 revealed C-7 (δ 162.13), which also correlated with a 
methoxy group (δH 3.85). A three-bond HMBC cross-peak from H-6 identified C-8 (δ 98.94), 
with its attendant H-8 (δ 6.70). Taken together, these data demonstrate that 13 is 3-
hydroxymethyl-4,7-dimethoxy-5-methylcoumanin, named cluteolin M. 
2.1.14. Compounds 14-21 
A further eight coumarins (14-21) were also separated and purified from the 
dichloromethane extract of C. lanceolata. The spectroscopic and other physical data for 
these compounds were consistent with those reported previously for samples which had 
been isolated from other plants or had been prepared synthetically. Furthermore, single 
crystal X-ray analysis confirmed the structures of 14-17, 19,20. Compounds 14-18 were 
isolated from C. abyssinica (Waigh et al., 1991), while 15 has also been synthesised 
unequivocally (Bohlmann & Wienhold, 1979), leading to structural revision of earlier claimed 
natural products. Faiella et al. (2014) identified 19,20 (7-demethyl-8-methoxycoumarsabin 
and 8-methoxycoumarsabin, respectively) from Sideritis pullulans. The latter had also been 
identified as a constituent of Leucas inflata roots (Al Yousuf et al., 1999) and of Juniperus 
sabina (De Pascual et al., 1981); it has also been synthesised (Ahluwalia & Mukherjee, 1984). 
8-Methoxypereflorin 21 has been isolated from Perezia alamani var. oolepsis (Joseph-
Nathan et al., 1982) and from Mutisieae (Bohlmann & Zdero, 1977) and has been 
synthesised (Bohlmann &Wienhold, 1979). 
2.2. Determination of the ability of the compounds to enhance release of insulin  
Diabetes mellitus is considered as a metabolic disorder characterised by sustained 
increase in the concentration of glucose in blood. It is a chronic disease that occurs either by 
the deficiency in the glucose-triggered secretion of insulin by β-cells in the islets of the 
pancreas (Type 1 diabetes) or by lack of response of cells in the liver and of adipocytes to 
insulin (Type 1 diabetes).  Type-2 diabetes is a long-term metabolic disease in which the 
ability of peripheral cells to take up glucose from the blood in response to insulin is 
decreased (“insulin resistance”), leading to an increase in the concentration of glucose in the 
blood. There can also be some loss of glucose-stimulated release of insulin by the β-cells of 
the islets of Langerhans. Clinically used drugs for the treatment of Type 2 diabetes either 
enhance the production of insulin by the β-cells (sulfonylureas, e.g. tolbutamide, 
glibenclamide) or render the peripheral cells more sensitive to insulin, thus stimulating 
uptake of glucose (e.g. metformin). Inhibitors of the tankyrases also increase insulin-
stimulated uptake of glucose by adipocytes (Nathubhai et al. 2017). Type-1 diabetes also 
involves loss of glucose-stimulated release of insulin by the β-cells.  
C. lanceolata is a traditional anti-diabetic medicinal plant; therefore, we have 
evaluated the anti-diabetic potential of compounds 1-4,8-9,12,14-17,19,20 using an assay 
that evaluates their effect on the glucose-triggered insulin-secretory activity of freshly 
isolated murine islets (Fig. 3). At 16.7 mM glucose, the insulin-secretory activity of control 
islets was 18.8 ± 3.0 ng islet-1 h-1. A similar value has been reported earlier (Hameed et al., 
2018). Among the compounds tested at a single concentration (200 µM), 1,9,12,14,19,20 did 
not show any effect on the secretion of insulin. Some activity (broadly equivalent to that of 
the positive control glimepiride) was displayed by 2,8,15,17. Strikingly, 3,4,16 showed potent 
enhancement of the glucose-triggered secretion of insulin by the isolated islets, showing 3.1-
fold, 4.7-fold and 5.5-fold enhancement, respectively, with glimepiride only showing 2.1-fold 
enhancement. The strong stimulation of glucose-triggered release of insulin helps to 
rationalise the traditional use of the plant C. lanceolata. Thus this plant may be considered 
as a valuable herbal remedy for diabetes. 
There is no clear prima facie structure-activity relationship distinguishing potent 
stimulators from weaker stimulators and their biochemical target is, as yet, unknown but 
these 5-methylcoumarins represent interesting new lead structures for further development 
of drugs to treat type-2 diabetes. Further studies will be needed to determine the 
mechanism(s) of their activity. 
3. Conclusion 
This phytochemical study into dichloromethane extract of the aerial parts of the plant Clutia 
lanceolata has yielded thirteen previously unreported 5-methylcoumarins, including 
sulphides and sulfoxides, namely cluteolin A to M (1-13), along with eight known coumarins 
(14-21).  Our initial investigation demonstrates the anti-diabetic potential of the extracts and 
that the activity of stimulation of glucose-triggered secretion of insulin by murine pancreatic 
islets is evident for compounds 2-4,8,15-17. In particular, 3,4,16 show very strong activity 
and warrant further study and development. 
4. Experimental 
4.1. Plant material 
The plant material was procured from Shafat village, Baha, Kingdom of Saudi Arabia 
(KSA), in February 2015 in the wet season and was formally identified by Dr M. Yousuf 
(taxonomist).  A voucher specimen (16069) was logged in the Herbarium of the College of 
Pharmacy, King Saud University, Riyadh, KSA. 
4.2. Extraction and isolation 
Drying of the aerial portions of Clutia lanceolata Forssk, (Peraceae) was achieved in 
the shade.  Once dried, the plant material was ground into a powder.  Extractions with 
solvents were conducted at room temperature on the ground material (1.30 kg), using 
CH2Cl2 (3 × 5 L), followed by MeOH (3 × 5 L).  The solvents were evaporated from the 
extracts at 40°C under reduced pressure using a Büchi rotary evaporator (model R-215).  This 
yielded the CH2Cl2 extract (47.5 g) and the MeOH extract (41.8 g). The MeOH extract was 
suspended in distilled water and  partitioned in sequence with EtOAc (3 × 1 L) and butan-1-ol 
(pre-saturated with water) (3 × 1 L), which provided an EtOAc fraction (8.9 g), a butan-1-ol 
fraction (21.4 g) and some material remaining in the water fraction (9.0 g).  The CH2Cl2 
extract (40.0 g) subjected to column chromatography over silica gel and eluted with gradient 
of hexane / EtOAc (1:0 → 1:3); the column was then flushed with MeOH. The fractions 
obtained were analysed by using TLC and the similar fractions were combined. This afforded 
forty-one fractions (Fr. 1 – Fr. 41).  Further work on these fractions led to the isolation of 
thirteen previously unreported compounds, in addition to eight known compounds.  Scheme 
1 (Supplementary Information) depicts the detailed isolation scheme. 
4.3. Isolation of islets and insulin secretion assay 
Islets of Langerhans were isolated from the pancreata of male BALB/c mice from the 
animal house of the International Centre for Chemical and Biological Sciences (ICCBS), 
University of Karachi, Pakistan.  The animals were anaesthetised with sodium thiopental and, 
after surgical opening of the abdomen; the pancreas was distended by injection of 1.0 mg 
mL-1 collagenase solution (Sigma, St. Louis, MO, USA) into the bile duct.  After careful 
removal, the distended pancreas was subjected to digestion with collagenase at 37°C for 15 
min.  The digested islets were further purified by centrifugation at 1000 rpm for 1 min, 
followed by filtration using a pre-wetted 70 µm cell strainer. 
Insulin secretion studies were performed in static incubations.  Islets were hand-
picked into Eppendorf tubes and were pre-incubated in Krebs-Ringer bicarbonate (KRB) 
buffer solution containing bovine serum albumin (0.1%) and glucose (3.0 mM).  Thereafter, 
batches of three size-matched islets were incubated for 60 min in KRB buffer with glucose 
(16.7 mM), in the presence of individual test compounds.  Chilling of the tubes on ice 
terminated the incubation.  The supernatant solution was removed and stored at -40 °C until 
it was assayed for insulin.  The secreted insulin was measured using an Ultra-Sensitive 
Mouse Insulin ELISA kit (Crystal Chem Inc., IL, USA) and was normalised for the number of 
islets.  Test compounds were examined along with a reference (positive control) compound 
glimepiride (Sigma) and a vehicle control (negative control). 
4.4. General experimental procedures 
The NMR spectra were obtained using a Bruker Avance spectrometer operating at 
700 MHz for 1H NMR and 175 MHz for 13C NMR. Conventional pulse sequences were used 
for COSY, HSQC and HMBC spectra. Chemical shift values stated in δ (ppm), using internal 
standard SiMe4 or the residual solvent peak for calibration; coupling constants (J) are given 
in Hz.  Ultra-high-accuracy mass analysis was performed on a Nano-Flow (Triversa 
Nanomate; Advion Biosciences Limited, Norfolk, UK) linear-trap quadrupole Fourier 
transformation ion cyclotron resonance mass spectrometry (FT-ICR-MS) Ultra device. The 
melting points were measured on a Büchi B-545 Melting Point apparatus.  IR spectra 
recorded on a Bruker spectrometer. UV spectra were measured on UV.1601 PC (Shimadzu).   
Column chromatography (CC) employed silica gel 60 (230-400 µm; Merck, 
Darmstadt) and LiChroprep* RP-18 (40–63 μm, Merck) Centrifugal Thin-Layer 
Chromatography (CTLC) was conducted on a Chromatotron (Ser. No.30 G, Harrison Research, 
USA).  UV254 fluorescence indicator (Merck) was used for TLC plate analyses.  Compounds 
were visualised under UV radiation in CAMAG UV Cabinet dual wavelength (254/366 nm) in 
addition to spraying with 4-methoxybenzaldehyde reagent followed by gentle warming with 
a heat gun. Semi-preparative HPLC was performed using Shimadzu system (Kyoto, Japan).  
This consisted of two columns: Shim-pack PREP-ODS (H) Kit (A) 250 mm × 4.6 mm i.d., 5 µm 
particles (B) 250 mm × 20 mm i.d; two LC-6AD solvent delivery pumps coupled with a 
Rheodyne manual injector; communications bus module CBM-20A; a multi-wavelength 
photodiode array detector (SPD-M20A) and an FRC-10A fraction collector.  All connected to 
a computer system with Intel CoreDUO with Microsoft Windows XP and Shimadzu’s LC 
solution software. Analytical HPLC was performed using the column under gradient 
conditions with the mobile phase (MeCN/H2O) programmed linearly at 1.0 mL min−1.  The UV 
detection wavelengths were 210 and 254 nm.  The chromatographic separation HPLC was 
performed using column and preparative HPLC conditions as for analytical HPLC, except that 
the flow rate was 20 mL min−1. 
X-Ray crystal data were acquired upon a Rigaku 007HF diffractometer, equipped 
with: Varimax confocal mirrors; an AFC11 goniometer; a HyPix 6000 detector and an Oxford 
Cryosystems, low-temperature device, operating at T = 100(2) K.  Crystals were mounted on 
a MITIGEN holder, with perfluoroether oil. The crystal structures were subsequently solved 
using the structure solution program Olex2 (Dolomanov et al., 2009), in conjunction with the 
ShelXT (Sheldrick, 2015a), using the Intrinsic Phasing solution method.  The model was 
refined with version 2014/7 of ShelXL (Sheldrick, 2015b) using Least Squares minimisation. 
4.5. Summary of analytical data for compounds 1-13 
 Cluteolin A (1): C12H14O2S; mp 90.9°C; UV (CHCl3) λmax (log ε): 302.8 (4.10); IR (CHCl3) 
νmax 2922, 1704, 1600, 1455 cm-1; for HRESIMS see text; for 1H and 13C NMR, see Table 1. 
 Cluteolin B (2): C13H14O3S; mp 93.8°C; UV (CHCl3) λmax (log ε): 331.2 (3.84); IR (CHCl3) 
νmax 2920, 2851, 1710, 1610, 1538, 1450 cm-1; for HRESIMS see text; for 1H and 13C NMR, see 
Table 1. 
Cluteolin C (3): C13H14O4S; mp 179.6°C; UV (CHCl3) λmax (log ε): 324.0 (4.27), 287.8 
(4.26), 258.6 (4.23); IR (CHCl3) νmax 2919, 1719, 1599, 1539 cm-1; for HRESIMS see text; for 1H 
and 13C NMR, see Table 1. 
Cluteolin D (4): C11H10O3S; mp 256.8°C; UV (CHCl3) λmax (log ε): 308.0 (4.13), 283.8 
(4.16), 258.4 (4.20); IR (CHCl3) νmax 3368, 2918, 1703, 1542, 1418 cm1; for HRESIMS see text; 
for 1H and 13C NMR, see Table 1. 
Cluteolin E (5). C13H14O4S; mp 206.5°C; UV (CHCl3)  λmax (log ε): 329.00 (4.01), 264.20 
(3.65), 239.20 (3.75) ; IR (CHCl3) νmax 3352, 2924, 1703, 1593, 1448 cm1; for HRESIMS see 
text; for 1H and 13C NMR, see Table 2. 
Cluteolin F (6): C12H12O4S; mp 150.1°C; UV (CHCl3) λmax (log ε): 333.40 (3.81), 261.00 
(3.32), 239.40 (3.54) ; IR (CHCl3) νmax 2925, 2353, 1729, 1604, 1454 cm-1; for HRESIMS see 
text; for 1H and 13C NMR, see Table 2. 
Cluteolin G (7): C13H14O5S; mp 215.4°C; UV (CHCl3) λmax (log ε): 343.2 (3.77), 283.8 
(4.16), 239.2 (3.79); IR (CHCl3) νmax 2918, 2850, 1711, 1594, 1464 cm-1; for HRESIMS see text; 
for 1H and 13C NMR, see Table 2. 
Cluteolin H (8): C12H12O3; mp 124.6°C; UV (CHCl3) λmax (log ε): 326.8 (3.83); IR (CHCl3) 
νmax 2918, 1696, 1608, 1450 cm-1; for HRESIMS see text; for 1H and 13C NMR, see Table 2. 
Cluteolin I (9): C12H12O4; mp 152.2°C; UV (CHCl3) λmax (log ε): 324.4 (4.10); IR (CHCl3) 
νmax 3347, 1698, 1600, 1503, 1459 cm-1; for HRESIMS see text; for 1H and 13C NMR, see Table 
3. 
Cluteolin J (10): C13H14O5; mp 162.8°C; UV (CHCl3) λmax (log ε): 336.4 (4.01), 298.8 
(3.98), 291.8 (3.99), 239.8 (3.98); IR (CHCl3) νmax 3355, 2928, 1694, 1611, 1451 cm-1; for 
HRESIMS see text; for 1H and 13C NMR, see Table 3. 
Cluteolin K (11): C13H14O4; mp 123.2°C; UV (CHCl3) λmax (log ε): 323.6 (3.70), 261.0 
(3.36), 239.2 (3.75); IR (CHCl3) νmax 2953, 1711, 1593, 1505, 1450 cm-1; for HRESIMS see text; 
for 1H and 13C NMR, see Table 3. 
Cluteolin L (12): C12H12O4; mp 166.4°C; UV (CHCl3) λmax (log ε): 286.8 (4.01); IR (CHCl3) 
νmax 3435, 2918, 2850, 1668, 1591, 1559, 1457 cm-1; for HRESIMS see text; for 1H and 13C 
NMR, see Table 4. 
Cluteolin M (13): C13H14O5; mp 114.8°C; UV (CHCl3) λmax (log ε): 323.4 (3.97); IR 
(CHCl3) νmax 3410, 2851, 1707, 1598, 1456 cm-1; for HRESIMS see text; for 1H and 13C NMR, 
see Table 4. 
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Table 1. NMR data for 1-4 (700 MHz (1H), 175MHz (13C)). 
Position 1 (CDCl3) 2 (CDCl3) 3 ((CD3)2SO) 4 ((CD3)2SO) 
 δH  
(J Hz) 




2  160.53 Cq  160.87 Cq  157.45 Cq  157.45 Cq 
3  130.16 Cq  127.06 Cq 5.88 s 103.70 CH 6.09 s 106.49 CH 
4  151.66 Cq  151.65 Cq  159.79 Cq  159.91 Cq 
4a  120.18 Cq  113.91 Cq  111.62 Cq  117.90 Cq 
5  136.87 Cq  138.42 Cq  132.23 Cq  125.49 Cq 
6 7.09 d 
(7.5) 
128.85 CH 6.68 s 116.91 CH 6.90 s 113.71 CH 6.97 d 
(8.3) 
127.79 CH 
7 7.31 t 
(7.5) 
129.88 CH  160.47 Cq  153.71 Cq 7.00 d 
(8.2) 
117.66 CH 
8 7.18 d 
(7.5) 
115.48 CH 6.68 s 99.03 CH  133.80 Cq  143.67 Cq 
8a  152.22 Cq  154.13 Cq  147.49 Cq  142.11 Cq 
R3 2.46 s 17.41 CH3 2.43 s 16.98 CH3     
R4 2.36 s 20.21 CH3 2.35 s 20.13 CH3 2.50 s 15.75 CH3 2.58 s 15.81 CH3 
5-Me 2.89 s 24.98 CH3 2.86 s 25.25 CH3 2.70 s 24.77 CH3 2.71 s 24.16 CH3 
R6         
R7   3.83 s 55.67 CH3 3.83 s 56.16 CH3   





Table 2. NMR data for 5-8 (700 MHz (1H), 175MHz (13C)). 
Position 5 ((CD3)2SO) 6 ((CD3)2SO) 7 (CDCl3) 8 (CDCl3) 
 δH δC type δH 
(J Hz) 
δC type δH δC type δH δC type 
2  159.41 Cq  158.76 Cq  159.31 Cq  162.82 Cq 
3  124.96 Cq 6.83 s 107.73 CH 7.22 s 110.06 CH  121.46 Cq 
4  151.35 Cq  166.57 Cq  165.62 Cq 7.62 s 136.65 CH 
4a  112.41 Cq  108.35 Cq  108.57 Cq  112.28 Cq 
5  130.83 Cq  137.24 Cq  127.83 Cq  136.32 Cq 
6 6.69 s 117.17 CH 6.87 m 115.98 CH  145.15 Cq 6.66 s 113.86 CH 
7  146.58 Cq  162.14 Cq  156.59 Cq  161.45 Cq 
8  130.83 Cq 6.99 d 
(2.9) 
99.61 CH 6.86 s 99.74 CH 6.66 s 98.42 CH 
8a  132.41 Cq  156.01 Cq  152.19 Cq  155.48 Cq 
R3 2.29 s 16.56 CH3     2.20 s 17.38 CH3 
R4 2.36 s 19.78 CH3 2.80 s 43.21 CH3 2.77 s 43.59 CH3   
5-Me 2.72 s 24.34 CH3 2.49 s 23.33 CH3 2.47 s 15.88 CH3 2.45 s 18.48 CH3 
R6     3.80 s 60.86 CH3   
R7 10.2 br  3.86 s 56.04 CH3 3.95 s 56.37 CH3 3.83 s 55.55 CH3 






Table 3. NMR data for 9-11 (700 MHz (1H), 175MHz (13C)). 
Position 9 (CDCl3) 10 (CD3)2SO) 11 (CDCl3) 
 δH δC type δH δC type δH δC type 
2  161.83 Cq  163.38 Cq  161.17 Cq 
3  121.11 Cq  109.87 Cq  120.66 Cq 
4 7.61 s 137.34 CH  166.59 Cq 7.93 s 137.57 CH 
4a  112.58 Cq  108.84 Cq  112.35 Cq 
5  130.75 Cq  119.48 Cq  130.80 Cq 
6 6.72 s 113.22 CH  141.38 Cq 6.95 s 110.50 CH 
7  146.93 Cq  150.49 Cq  153.58 Cq 
8  131.76 Cq 6.93 s 97.64 CH  133.17 Cq 
8a  150.32 Cq  147.54 Cq  146.96 Cq 
R3 2.20 s 17.44 CH3 2.00 s 10.35 CH3 2.09 s 18.03 CH3 
R4   3.80 s 60.70 CH3   
5-Me 2.41 s 18.33 CH3 2.49 s 12.40 CH3 2.45 s 16.69 CH3 
R6   8.79 br    
R7 6.03 s  3.88 s 56.24 CH3 3.87 s 56.21 CH3 







Table 4. NMR data for 12-13 (700 MHz (1H), 175MHz (13C)). 
Position 12 (CDCl3) 13 (CDCl3) 
 δH (J Hz) δC type δH (J Hz) δC type 
2  164.39 Cq  164.83 Cq 
3  114.50 Cq  111.60 Cq 
4  168.18 Cq  168.71 Cq 
4a  116.24 Cq  109.68 Cq 
5  137.09 Cq  138.53 Cq 
6 7.08 d (7.5) 128.31 CH 6.66 s 116.48 CH 
7 7.40 t (7.9) 131.09 CH  162.13 Cq 
8 7.21 d (8.3) 115.40 CH 6.70 s 98.94 CH 
8a  154.26 Cq  156.25 Cq 
R3 4.68 s 56.25 CH2 4.65 d (6.6) 56.28 CH2 
R4 4.06 s  63.28 CH3 4.04 s 63.22 CH3 
5-Me 2.70 s 22.61 CH3 2.63 s 22.78 CH3 
R6     
R7   3.85 s 55.78 CH3 



















Fig. 1. Structures of 5-methylcoumarins isolated from Clutia lanceolata. Compounds 1-13 are 
previously undescribed, whereas 14-21 are known but are isolated from this plant for the first 













Cpd. R3 R4 R6 R7 R8
8 Me H H OMe H
9 Me H H OH OMe
10 Me OMe OH OMe H
11 Me H H OMe OMe
12 CH2OH OMe H H H
13 CH2OH OMe H OMe H
14 Me OMe H H H
15 H SMe H H H
16 H SMe OMe OH H
17 H SMe OMe OMe H
18 Me OMe OMe OMe H
19 Me OMe H OH OMe
20 Me OMe H OMe OMe
21 H OMe H H OMe
Cpd. R3 R4 R6 R7 R8
1 Me SMe H H H
2 Me SMe H OMe H
3 H SMe H OMe OMe
4 H SMe H H OH
5 Me SMe H OH OMe
6 H S(O)Me H OMe H












Fig. 2. X-Ray crystal structures determined for 1,8,9,11,12,14-17,19,20. Atoms are shown as thermal 






































Fig. 3. Effects of test compounds (from Clutia lanceoleta) on the glucose-triggered secretion of insulin from 
murine islets.  Islets were incubated for 1 h at 37°C in KRB buffer containing glucose (16.7 mM) in the absence 
(Control) or presence of test compounds and the secreted insulin was measured. Values are mean ± SD from 
three independent experiments. *P <0.05, **P <0.01, ***P <0.001 compared with the control value. 
